Loading
Latest filing published 15 Dec 2006 for KOS PHARMACEUTICALS INC, €295k.
No signal scores available.
John Brademas discloses dealings in KOS Pharmaceuticals Inc to SEC (Form 4). The record holds 2 filings, for trades running from 27 April 2006 to 13 December 2006.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 15 December 2006, the filings show a transaction worth €295k in KOS Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations